Abstract: The present invention relates to a novel composition based on ABA triblock copolymers comprising two styrene thermoplastic end blocks A and a central elastomeric block B which is a saturated olefin, comprising at least one resin chosen from the aromatic resins, that can be used in particular for producing an interface dressing with reinforcement, with a support or which is self-supported, preferably self-supported. The present invention relates to a self-supported interface dressing which can be easily handled since it has good tear strength.

Abstract: The disclosure relates to a method for transmitting an item of information in a communication channel linking a transmitter to a recipient, the method including the following successive steps: the determination, by the transmitter, of a first intelligible sound signal representative of the item of information to be transmitted, the acoustic processing, by the transmitter, of the first sound signal so as to produce a second sound signal unintelligible to the recipient, the transmission of the second sound signal from the transmitter to the recipient, the transmission of the first sound signal from the transmitter to the recipient, the transmission of the first sound signal being triggered by the transmission of the second sound signal, the second transmission of the second sound signal from the transmitter to the recipient, the second transmission of the second sound signal being triggered by the transmission of the first signal.

Abstract: An interface dressing (1) comprising an elastomeric matrix (5), the elastomeric matrix (5) being provided with a plurality of through-holes (6), each through-hole (6) having a contour (C) around a central axis (A), in which at least some of the plurality of through-holes (6) are arranged so as to form at least one pattern in which each through-hole (6) is adjacent to at least one other through-hole (6), the adjacent through-holes (6) having contours (C), images of which, when moved in translation in a plane perpendicular to the central axes (A) in order to merge images of said central axes (A) by means of said translational movement, do not become superposed.

Abstract: The present invention relates to a dressing providing for the controlled and sustained release of metformin. The present invention relates in particular to the use of a resin selected from the aromatic resins, to promote the release of metformin into an elastomeric matrix.

Abstract: The present invention relates to the use, as an agent for salting out an active substance in a composition for a dressing, of a copolymer of a salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulphonic acid and the 2-hydroxyethyl ester of propenoic acid. It also relates to dressings of the type comprising at least one fatty substance and/or an elastomeric matrix and at least one active substance, which incorporate the aforementioned copolymer.

Abstract: The subject of the present invention is a composite wound packing material comprising a casing enclosing a material, or an assembly of materials, forming fluid flow channels, said casing being composed of a self-supporting interface material formed from a thin layer of a composition comprising a hydrophobic matrix and comprising through-holes, said hydrophobic matrix comprising, per 100 parts by weight of a styrene/saturated olefin/styrene triblock copolymer having a viscosity of between 0.2 and 2 Pa·s, as measured in a 10% (weight/weight) solution in toluene, from 400 to 1220 parts by weight of a plasticizer, preferably a plasticizing oil, and from 0 to 720 parts by weight of petroleum jelly, it being specified, moreover, that the total amount of plasticizer and petroleum jelly is greater than or equal to 750 parts by weight and the amount of petroleum jelly is between 400 and 720 parts by weight when the amount of plasticizer is between 1000 and 1220 parts by weight.

Abstract: The subject matter of the present invention is, according to a first aspect, a dressing comprising an interface layer, characterised in that said interface layer comprises a weave coated with an elastomeric matrix comprising metformin, the salts and the complexes thereof. The subject matter of the invention is also a dressing comprising metformin, characterised in that the percentage of metformin released after 72 hours is between 40 and 100% of the quantity of metformin inserted in the dressing. Moreover, the subject matter of the invention is a method for producing said dressing as well as the use thereof for healing a wound.

Abstract: The invention is directed to a light source device (10) comprising a light emitting element (12) for emitting a blue light having a wavelength ranging from 435 to 500 nm, the light source device (10) being configured to provide the blue light to at least one cell (C) at a transmitted fluence ranging from 0.01 to 18. J/cm2 to promote or induce growth and proliferation of the cell (C) and wherein the light emitting element (12) has a power density ranging from 0.05 to 30 mW/cm2. The invention is also directed to a light source assembly comprising a product adapted to be in contact with the skin or a wound and a light source device (10) connected to the product for providing blue light to at least one skin cell (C), preferably of the wound.

Abstract: An article having properties allowing same to absorb a body fluid. The article includes at least three paths for the propagation of fluid from a fluid capture zone to at least one storage and/or evaporation area, each fluid propagation path being delimited by a fluid barrier preventing the passage of liquid from one path to another.

Abstract: One subject of the present invention is a dressing essentially consisting of: an absorbent nonwoven compress formed from a mixture: of bicomponent thermal bonding non-absorbent fibers, of core-shell type, said core being made of polyester (polyethylene terephthalate, PET) and the shell being made of polyethylene; of bicomponent superabsorbent fibers of core-shell type with a core made of polyacrylonitrile and a shell made of polyacrylate; and a net fabric made from a hydrocolloid elastomer mass partially covering the face of the compress intended to come into contact with the wound. This product is especially intended to promote the healing of chronic wounds by optimizing the debridement.

Abstract: The invention relates to a dermatological treatment device (1) including a laser head (2) capable of shooting a laser beam (3) towards a target region (4) of the skin (5) of a patient, a pyrometer (6) capable of measuring the temperature (T) of the skin (5) in said target region (4), a timer (7) capable of measuring the duration (D) of the laser shot, and a control means (8) capable of selectively activating or deactivating a laser shot, the control means (8) being configured to deactivate the laser shot when the duration (D) of the shot reaches a duration threshold in seconds (Sd) as determined by a linear function in the form Sd=(To?T)/C, where T is the measured temperature (T) of the skin, To is a target temperature, and C is an average heating coefficient of the skin.

Abstract: Disclosed is a protective sleeve (1) for a dermatological treatment device comprising a laser head for firing a laser beam. The sleeve (1) comprises: a rigid shell (2) which is shaped such that it can be placed over the laser head and has a window (4) that can be positioned opposite the laser beam; a contact wall (5) arranged around the window (4) for contacting an area around a target area; and a means for attachment to the device, the attachment means being positioned as close as possible to the contact wall (5).

Abstract: The invention relates to a device (1) for dermatological treatment, comprising a laser head (2) suitable for directing a laser beam (3) towards a target zone (4), at least one fan (5) suitable for dissipating the heat emitted by the laser head (2), and at least one monitoring means (6) suitable for detecting a fault in at least one fan (5) and for controlling at least one means (7) for inhibiting the laser beam (3) when a fault is detected.

Abstract: The present invention relates to a nanofilm including at least one polycation and one polysulfated oligosaccharide. The present invention also relates to the nanofilms obtainable by simultaneously or alternately sputtering at least one polycation solution and at least one polysulfated oligosaccharide solution and to the use of said nanofilms on skin, skin conditions, wounds, or mucous membranes. The present invention also relates to a nanofilm for the use thereof in a method for releasing polysulfated oligosaccharide upon contact with exuding wounds.

Abstract: The subject matter of the present invention is a synthetic polysulfated oligosaccharide having 1 to 4 monosaccharaide units, salts thereof, or complexes thereof, at a concentration greater than or equal to 70 mg/mL, for use thereof for activating angiogenesis, in particular for activating angiogenesis during wound healing.

Abstract: The present invention relates to a therapeutic compound comprising: an agent that inhibits the activity of at least one gene selected from the group consisting of MAF, MEOX2, SIX2 and homologs thereof having at least 50% identity with said genes and/or an agent that enhances the activity of at least one gene selected from the group consisting of CREB5, E2F1, EGR2, HIC1, IRF7, JUN, MYC, SRF, STAT4, TCF4, FOXS1, GLI1, SOX9 and homologs thereof having at least 50% identity with said gene for use in the treatment of wounds, preferably chronic wounds.

Abstract: The disclosure relates to a method for transmitting an item of information in a communication channel linking a transmitter to a recipient, the method including the following successive steps: the determination, by the transmitter, of a first intelligible sound signal representative of the item of information to be transmitted, the acoustic processing, by the transmitter, of the first sound signal so as to produce a second sound signal unintelligible to the recipient, the transmission of the second sound signal from the transmitter to the recipient, the transmission of the first sound signal from the transmitter to the recipient, the transmission of the first sound signal being triggered by the transmission of the second sound signal, the second transmission of the second sound signal from the transmitter to the recipient, the second transmission of the second sound signal being triggered by the transmission of the first signal.

Abstract: A compression bandage formed by the assembling of a nonwoven based on short conjugate fibers which have been crimped and of a nonelastic material. The compression bandage can be used in a bilayer compression system, in particular for the prevention or treatment of venous pathologies.

Abstract: A compression bandage that is formed by the assembling of a self-adhesive nonwoven based on short conjugate fibers which have been crimped and of an elastic material, the effectiveness of which increases over time. The bandage can be used, alone or in a bilayer compression system, for the prevention or treatment of venous pathologies or lymphedema.

Abstract: A self-adhesive compression bandage, in particular for the treatment and prevention of pathologies of venous origin and lymphedema. This bandage is manufactured by the assembling of two self-adhesive nonwovens based on short conjugate fibers which have been crimped. The fibers are preferably made of polyester. The bandage can in addition comprise a supplementary layer.